Clinimetric evaluation of a new overall disability scale in immune mediated polyneuropathies
暂无分享,去创建一个
[1] K. Toyka,et al. Assessing grip strength in healthy individuals and patients with immune‐mediated polyneuropathies , 2000, Muscle & nerve.
[2] P. V. van Doorn,et al. Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies , 2000, Neurology.
[3] P. Schmitz,et al. Fatigue in immune-mediated polyneuropathies , 1999, Neurology.
[4] P. Schmitz,et al. Residual physical outcome and daily living 3 to 6 years after Guillain-Barré syndrome , 1999, Neurology.
[5] J. Gabriel,et al. Paraproteinaemic Neuropathies , 1999, Bailliere's clinical neurology.
[6] B. Sharrack,et al. Scale development and Guy’s Neurological Disability Scale , 1999, Journal of Neurology.
[7] R. D. de Haan,et al. Impact of neurologic signs and symptoms on functional status in peripheral neuropathies , 1999, Neurology.
[8] H. Hartung,et al. Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies. , 1998, Current opinion in neurology.
[9] W. Hacke,et al. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome , 1997 .
[10] A. Thompson,et al. Evaluating neurological outcome measures : the bare essentials , 2022 .
[11] J. Katz,et al. Measuring relevant change: an emerging challenge in rheumatologic clinical trials. , 1995, Arthritis and rheumatism.
[12] M H Liang,et al. Evaluating measurement responsiveness. , 1995, The Journal of rheumatology.
[13] G. Bydder,et al. Brain swelling in first hour after coronary artery bypass surgery , 1993, The Lancet.
[14] R. Hughes,et al. Reasons for Persistent Disability in Guillain-Barré Syndrome , 1993 .
[15] P. Schmitz,et al. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. , 1992, The New England journal of medicine.
[16] M. Feinleib,et al. Statistical Models for Longitudinal Studies of Health , 1992 .
[17] P. Schmitz,et al. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.
[18] Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) , 1991, Neurology.
[19] M. Liang,et al. Comparisons of Five Health Status Instruments for Orthopedic Evaluation , 1990, Medical care.
[20] B. Ford. International Classification of Impairments, Disabilities and Handicaps , 1984, Releve epidemiologique hebdomadaire.
[21] M. Matthay,et al. Guillain-Barré syndrome: psychosocial aspects of management. , 1983, Psychosomatics.
[22] R. Hughes,et al. CONTROLLED TRIAL OF PREDNISOLONE IN ACUTE POLYNEUROPATHY , 1978, The Lancet.
[23] D. Cornblath,et al. Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.
[24] Frank E. Harrell,et al. The restricted cubic spline hazard model , 1990 .
[25] R. Bloch,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[26] G. Guyatt,et al. Measuring change over time: assessing the usefulness of evaluative instruments. , 1987, Journal of chronic diseases.
[27] B. Ford. International classification of impairments, disabilities and handicaps. , 1984, The Medical journal of Australia.